Trevena (NASDAQ:TRVN) Earns Sell Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Trevena (NASDAQ:TRVN – Free Report) in a report issued on Monday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Trevena Stock Performance TRVN stock opened at $0.72 on Monday. Trevena has a 1 year low of $0.51 and a 1 year high of $3.28. The […]

Leave a Reply

Your email address will not be published.

Previous post Brain Type 8: Psychologists Say Humans Have Eight Types of Intelligence, Know Yours! 
Next post The Revolutionary 1954 Jaguar XK120 owned by David Gandy